Home> Products> sglt2 inhibition

{ "products": [ { "_id": "68b6d6c76f14ecfa6add5d56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 200", "description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2170, "imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:36:39.17Z", "updatedon": "2025-09-02T11:36:39.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35ad2c50c07ee3dcaceda", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 12.5mg, Metformin Hydrochloride 1000mg", "description": "GLIEMPAFLOZIN MET 12.5mg/1000mg is an advanced combination medication formulated for the management of Type 2 Diabetes Mellitus. This dual-action therapy helps improve glycemic control by reducing blood sugar levels through two complementary mechanisms. It is ideal for individuals who require a combination of SGLT2 inhibition and biguanide therapy for effective blood sugar regulation. Along with a proper diet and regular exercise, this medication aids in better diabetes management and reduces the risk of diabetes-related complications.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control – Helps lower HbA1c levels.\nWeight Management – Empagliflozin aids in weight loss by eliminating excess glucose through urine.\nCardiovascular Benefits – Reduces the risk of heart disease in diabetic patients.\nImproves Insulin Sensitivity – Enhances the body's response to insulin.\nSupports Kidney Function – Empagliflozin helps protect kidney function by reducing strain on the nephrons.\nReduces the Risk of Hypoglycemia – Unlike some other diabetes treatments, this combination has a lower risk of causing low blood sugar episodes.\n \nHow Does It Work?\n \n\nEmpagliflozin works by blocking SGLT2 (Sodium-Glucose Co-Transporter-2) in the kidneys, leading to the excretion of excess glucose through urine.\nMetformin decreases hepatic glucose production, slows glucose absorption from the intestines, and enhances insulin sensitivity in peripheral tissues.\nTogether, these mechanisms ensure better glycemic control while reducing the burden on the pancreas and insulin production.\n \nDirections for Use:\n \n\n Dosage: Take as prescribed by your healthcare provider.\nTiming: Usually taken once or twice daily with meals to reduce gastrointestinal side effects.\nSwallow Whole: Do not crush, chew, or break the tablet.\nLifestyle Recommendations: Maintain a healthy diet, regular physical activity, and weight management for best results.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET 12.5mg/1000mg is well-tolerated, some individuals may experience mild to moderate side effects, such as:\n\nFrequent urination (due to Empagliflozin)\nDehydration and low blood pressure\nGastrointestinal issues like nausea, diarrhea, or stomach upset\nYeast infections (especially in women)\nVitamin B12 deficiency (due to prolonged Metformin use)\nWarning: In rare cases, it may cause lactic acidosis or diabetic ketoacidosis. Consult your doctor immediately if you experience severe weakness, dizziness, difficulty breathing, or chest pain.", "price": 185.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "lower risk", "nephrons reduces", "reducing strain", "weight management", "diabetes management", "chest pain", "doctor immediately", "lactic acidosis", "rare cases", "prolonged metformin", "nausea diarrhea", "experience mild", "crush chew", "glycemic control", "mechanisms ensure", "peripheral tissues", "kidneys leading", "diabetes treatments", "hypoglycemia unlike", "bodys response", "heart disease", "weight loss", "medication aids", "regular exercise", "proper diet", "biguanide therapy", "sglt2 inhibition", "complementary mechanisms", "empagliflozin dehydration", "excess glucose", "eliminating excess glucose", "work empagliflozin works", "diabetic ketoacidosis consult", "frequent urination due", "moderate side effects", "gliempaflozin met 125mg1000mg", "results side effects", "healthcare provider timing", "insulin production directions", "enhances insulin sensitivity" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2047, "imageuri": "https://productimages.withfloats.com/actual/67a35b5ff147b76947dad0ce.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35b5ff147b76947dad0ce.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:34:26.615Z", "updatedon": "2025-03-22T10:19:44.132Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-1000mg/2047", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 1000mg ", "category": "", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d6ac7a81222f3e95890cfd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Efavirenz IP (600mg)", "description": "Efenavirez 600\nEfavirenz IP (600mg)\nEfenavirez 600 is a potent antiretroviral medication designed to combat HIV-1 infection effectively. The primary ingredient, Efavirenz IP (600mg), belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and is commonly used as part of combination therapy for the treatment of HIV/AIDS. Efenavirez 600 helps reduce the viral load in the body, improving immune function and preventing the progression of the disease.\n\n \n\nKey Benefits:\n \n\nEffective HIV-1 Treatment: Efenavirez 600 is highly effective in lowering the viral load in patients with HIV-1, improving their overall immune response.\nOnce-Daily Dosing: With a convenient once-daily dose, Efenavirez 600 simplifies the treatment regimen, promoting better adherence to therapy.\nPart of Combination Therapy: This medication is typically used alongside other antiretrovirals to provide a comprehensive approach to HIV treatment, reducing the risk of drug resistance.\n \n\nHow Does It Work?\n \n\nEfavirenz in Efenavirez 600 works by inhibiting the action of the reverse transcriptase enzyme, which is crucial for the replication of HIV-1. By binding to this enzyme, Efavirenz prevents the virus from converting its RNA into DNA, a necessary step for the virus to multiply within the host's cells. This inhibition reduces the overall viral load in the body, allowing the immune system to function more effectively and slowing the progression of the disease.\n\n \n\nDirections for Use:\n \n\nDosage: Efenavirez 600 is typically taken as one tablet daily, preferably at bedtime, to reduce potential side effects such as dizziness or drowsiness.\nAdministration: It is recommended to take this medication on an empty stomach or as directed by your healthcare provider. Ensure consistent use for maximum efficacy.\nMissed Dose: If a dose is missed, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the missed dose and resume your regular schedule. Do not double the dose.\n \n\nSide Effects:\n \n\nCommon Side Effects: Dizziness, drowsiness, trouble sleeping, and vivid dreams may occur as your body adjusts to the medication. These effects are usually mild and diminish over time.\nSerious Side Effects: Rarely, Efavirenz can cause severe mental/mood changes (such as depression, suicidal thoughts), liver problems, or severe allergic reactions. Contact your healthcare provider immediately if you experience any unusual symptoms or worsening side effects.\nPrecautions: Inform your healthcare provider of any pre-existing conditions, particularly mental health issues or liver problems, as Efavirenz may exacerbate these conditions.", "price": 1825.0, "discountamount": 547.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "next dose", "daily dose", "Efavirenz IP", "vivid dreams", "Key Benefits", "empty stomach", "HIV treatment", "immune system", "consistent use", "liver problems", "necessary step", "HIV-1 infection", "drug resistance", "immune function", "unusual symptoms", "trouble sleeping", "regular schedule", "maximum efficacy", "one tablet daily", "suicidal thoughts", "treatment regimen", "primary ingredient", "overall viral load", "combination therapy", "healthcare provider", "Common Side Effects", "Serious Side Effects", "mental health issues", "other antiretrovirals", "comprehensive approach", "worsening side effects", "potential side effects", "pre-existing conditions", "overall immune response", "Effective HIV-1 Treatment", "severe allergic reactions", "severe mental/mood changes", "reverse transcriptase enzyme", "potent antiretroviral medication", "non-nucleoside reverse transcriptase inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1944, "imageuri": "https://productimages.withfloats.com/actual/66d6acd8550f4b1ce97e94bc.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d6acd8550f4b1ce97e94bc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T06:28:10.781Z", "updatedon": "2024-09-03T06:28:10.781Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/efavirenz-ip-600mg-/1944", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Efenavirez 600", "category": "GENERAL RANGE", "tags": [ "efavirenz 600 mg tablet", "efavirenz 600 mg uses", "efavirenz 600 mg side effects", "efavirenz 600 mg uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c07d66641561b044696cc", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TARPEDO ER 50 ", "description": "TARPEDO ER 50 \nTapentadol HCL ER Tablets, (50mg)\nIntroduction:\n\nTARPEDO ER 50 contains Tapentadol HCL, an extended-release (ER) formulation designed for the management of moderate to severe chronic pain. With a dosage strength of 50mg, TARPEDO ER 50 provides sustained pain relief, improving the quality of life for patients who require long-term pain management.\nKey Features and Benefits:\n\nDual Mechanism of Action:\n\nOpioid Agonist: Tapentadol acts as a mu-opioid receptor agonist, providing potent analgesic effects by altering the perception of pain in the central nervous system.\nNorepinephrine Reuptake Inhibitor: It also inhibits the reuptake of norepinephrine, enhancing pain inhibition in the brain and spinal cord, contributing to its analgesic properties.\nExtended-Release Formulation:\n\nTARPEDO ER 50 is designed for extended release, ensuring a steady release of medication over a 12-hour period. This provides consistent pain control and reduces the need for frequent dosing.\nEffective Pain Management:\n\nSuitable for managing various types of chronic pain, including neuropathic pain, osteoarthritis, and lower back pain. TARPEDO ER 50 helps patients maintain daily activities and improve their overall quality of life.\nReduced Side Effects:\n\nCompared to other opioids, Tapentadol has a lower incidence of common opioid-related side effects such as nausea, vomiting, and constipation, making it a more tolerable option for long-term use.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended starting dose of TARPEDO ER 50 is 50mg twice daily, approximately every 12 hours. Dosage should be adjusted based on individual patient response and tolerability.\nTitration and Maintenance:\n\nThe dose may be increased in increments of 50mg every 3 days as needed to achieve adequate pain control. The maximum recommended dose is 500mg per day.\nAdministration Instructions:\n\nSwallow TARPEDO ER 50 tablets whole with water. Do not crush, chew, or split the tablets to avoid rapid release of the drug, which can increase the risk of adverse effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tarpedo-er-50-133971", "price": 148.0, "discountamount": 44.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "50mg", "life", "risk", "drug", "need", "Order", "EMAIL", "water", "500mg", "brain", "Action", "nausea", "option", "patients", "Benefits", "vomiting", "12 hours", "Titration", "medication", "perception", "increments", "information", "Maintenance", "spinal cord", "moderate to", "Introduction", "sterispharma", "sterisonline", "constipation", "tolerability", "Key Features", "CALL/WHATSAPP", "rapid release", "starting dose", "other opioids", "various types", "long-term use", "12-hour period", "osteoarthritis", "Initial Dosage", "Opioid Agonist", "steady release", "Dual Mechanism", "lower back pain", "pain inhibition", "lower incidence", "adverse effects", "overall quality", "dosage strength", "frequent dosing", "neuropathic pain", "daily activities", "extended release", "severe chronic pain", "analgesic properties", "Reduced Side Effects", "sustained pain relief", "adequate pain control", "central nervous system", "consistent pain control", "potent analgesic effects", "maximum recommended dose", "long-term pain management", "Tapentadol HCL ER Tablets", "Effective Pain Management", "mu-opioid receptor agonist", "individual patient response", "Administration Instructions", "Extended-Release Formulation", "Swallow TARPEDO ER 50 tablets", "Norepinephrine Reuptake Inhibitor", "extended-release (ER) formulation", "common opioid-related side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1903, "imageuri": "https://productimages.withfloats.com/actual/666c07da0b4fc76a99a41803.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c07da0b4fc76a99a41803.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:05:26.681Z", "updatedon": "2024-06-26T06:23:02.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tarpedo-er-50-/1903", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TARPEDO ER 50 ", "category": "NEUROLOGY RANGE", "tags": [ "TARPEDO ER 50", "", "Tapentadol HCL ER Tablets, (50mg)", "", "tapentadol 50 mg side effects", "long-term side effects of tapentadol" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c06e12a9e3612903d86ea", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TARPEDO ER 100 ", "description": "TARPEDO ER 100 \nTapentadol HCL ER Tablets (100mg)\nIntroduction:\n\nTARPEDO ER 100 contains Tapentadol HCL, an extended-release (ER) formulation designed to manage moderate to severe chronic pain. With a dosage strength of 100mg, TARPEDO ER 100 offers sustained pain relief, improving the quality of life for patients who require long-term pain management.\nKey Features and Benefits:\n\nDual Mechanism of Action:\n\nOpioid Agonist: Tapentadol acts as a mu-opioid receptor agonist, providing potent analgesic effects by altering the perception of pain in the central nervous system.\nNorepinephrine Reuptake Inhibitor: It also inhibits the reuptake of norepinephrine, enhancing pain inhibition in the brain and spinal cord, which contributes to its analgesic properties.\nExtended-Release Formulation:\n\nTARPEDO ER 100 is designed for extended release, ensuring a steady release of medication over a 12-hour period. This provides consistent pain control and reduces the need for frequent dosing.\nEffective Pain Management:\n\nSuitable for managing various types of chronic pain, including neuropathic pain, osteoarthritis, and lower back pain. TARPEDO ER 100 helps patients maintain daily activities and improve their overall quality of life.\nReduced Side Effects:\n\nCompared to other opioids, Tapentadol has a lower incidence of common opioid-related side effects such as nausea, vomiting, and constipation, making it a more tolerable option for long-term use.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended starting dose of TARPEDO ER 100 is 100mg twice daily, approximately every 12 hours. Dosage should be adjusted based on individual patient response and tolerability.\nTitration and Maintenance:\n\nThe dose may be increased in increments of 50mg to 100mg every 3 days as needed to achieve adequate pain control. The maximum recommended dose is 500mg per day.\nAdministration Instructions:\n\nSwallow TARPEDO ER 100 tablets whole with water. Do not crush, chew, or split the tablets to avoid rapid release of the drug, which can increase the risk of adverse effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tarpedo-er-100-133972", "price": 278.0, "discountamount": 83.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "need", "50mg", "drug", "risk", "life", "EMAIL", "water", "Order", "500mg", "100mg", "brain", "nausea", "Action", "option", "Benefits", "vomiting", "patients", "12 hours", "Titration", "medication", "increments", "perception", "spinal cord", "Maintenance", "information", "moderate to", "Introduction", "sterisonline", "constipation", "tolerability", "sterispharma", "Key Features", "CALL/WHATSAPP", "rapid release", "other opioids", "starting dose", "various types", "long-term use", "Opioid Agonist", "Dual Mechanism", "steady release", "12-hour period", "osteoarthritis", "Initial Dosage", "overall quality", "dosage strength", "lower incidence", "frequent dosing", "pain inhibition", "adverse effects", "lower back pain", "extended release", "neuropathic pain", "daily activities", "severe chronic pain", "analgesic properties", "Reduced Side Effects", "sustained pain relief", "adequate pain control", "central nervous system", "consistent pain control", "potent analgesic effects", "maximum recommended dose", "Effective Pain Management", "long-term pain management", "Tapentadol HCL ER Tablets", "mu-opioid receptor agonist", "Administration Instructions", "individual patient response", "Extended-Release Formulation", "Swallow TARPEDO ER 100 tablets", "Norepinephrine Reuptake Inhibitor", "extended-release (ER) formulation", "common opioid-related side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1902, "imageuri": "https://productimages.withfloats.com/actual/666c06e4117f82c50b0d0236.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666c06e4117f82c50b0d0236.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:01:21.805Z", "updatedon": "2024-06-26T06:25:00.472Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tarpedo-er-100-/1902", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TARPEDO ER 100 ", "category": "NEUROLOGY RANGE", "tags": [ "long-term side effects of tapentadol", "tapentadol er 100 mg", "TARPEDO ER100", "tapentadol 50 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666975897e4bb91e3091ff69", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CILOSTAZONE 100 ", "description": "CILOSTAZONE 100 \nCilostazol (100mg)\nIntroduction\nCILOSTAZONE 100 contains Cilostazol (100 mg), a potent medication used to treat the symptoms of intermittent claudication in individuals with peripheral artery disease (PAD). By improving blood flow and reducing pain during physical activity, Cilostazol enables patients to walk longer distances and engage more comfortably in daily activities.\n\nKey Ingredient and Its Benefits\nCilostazol (100 mg)\nImproved Blood Flow: Cilostazol works by inhibiting phosphodiesterase III, leading to an increase in cyclic AMP levels, which causes vasodilation and improves blood flow to the limbs.\nReduced Pain: It effectively reduces pain and discomfort in the legs associated with intermittent claudication, allowing patients to walk longer distances without pain.\nPlatelet Aggregation Inhibition: Cilostazol inhibits platelet aggregation, reducing the risk of blood clots and enhancing cardiovascular health.\nEnhanced Physical Activity: By alleviating symptoms of intermittent claudication, Cilostazol helps patients increase their physical activity and improve overall fitness.\nBenefits of CILOSTAZONE 100\nEffective Symptom Relief: CILOSTAZONE 100 provides robust relief from intermittent claudication symptoms, significantly reducing pain and discomfort in the legs.\nImproved Circulation: The medication enhances blood flow to the extremities, improving circulation and overall vascular health.\nIncreased Mobility: By reducing pain during walking, CILOSTAZONE 100 enables patients to increase their mobility and engage more actively in daily activities.\nPrevention of Blood Clots: Cilostazol’s platelet aggregation inhibition properties help prevent blood clot formation, reducing the risk of cardiovascular events.\nDosage and Administration\nDosage\nIntermittent Claudication: The typical dosage for adults is one tablet (100 mg) taken twice daily, 30 minutes before or 2 hours after breakfast and dinner. The dosage may be adjusted by the healthcare provider based on the patient’s response and specific health needs.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It should be taken on an empty stomach, either 30 minutes before or 2 hours after meals.\nConsistency: For optimal results, take CILOSTAZONE 100 at the same times each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/cilostazone-100-133550", "price": 191.5, "discountamount": 57.45, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "PAD", "risk", "legs", "Order", "EMAIL", "limbs", "meals", "water", "adults", "dinner", "walking", "patients", "response", "Benefits", "Oral Use", "breakfast", "Prevention", "Cilostazol", "same times", "discomfort", "one tablet", "full glass", "individuals", "CILOSTAZONE", "extremities", "blood clots", "Consistency", "bloodstream", "information", "Introduction", "sterispharma", "vasodilation", "Reduced Pain", "sterisonline", "CALL/WHATSAPP", "robust relief", "empty stomach", "typical dosage", "Key Ingredient", "overall fitness", "optimal results", "daily activities", "longer distances", "potent medication", "cyclic AMP levels", "Increased Mobility", "Improved Blood Flow", "healthcare provider", "blood clot formation", "Improved Circulation", "cardiovascular events", "cardiovascular health", "specific health needs", "Administration Dosage", "phosphodiesterase III", "overall vascular health", "Effective Symptom Relief", "peripheral artery disease", "Enhanced Physical Activity", "consistent medication levels", "intermittent claudication symptoms", "platelet aggregation inhibition properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1815, "imageuri": "https://productimages.withfloats.com/actual/6669758c8c6c791fd3b357ad.png", "tileimageuri": "https://productimages.withfloats.com/tile/6669758c8c6c791fd3b357ad.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T10:16:41.937Z", "updatedon": "2024-06-27T06:01:08.361Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cilostazone-100-/1815", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CILOSTAZONE 100 ", "category": "NEUROLOGY RANGE", "tags": [ "CILOSTAZONE 100", "Cilostazol 100mg price", "Cilostazol 100mg", "Cilostazol (100mg) usess", "", "Cilostazol mechanism of action", "cilostazol side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6669749c70774b1f84f67b0d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CILOSTAZONE 50 ", "description": "CILOSTAZONE 50 \nCilostazol (50mg)\nIntroduction\nCILOSTAZONE 50 contains Cilostazol (50 mg), a medication used primarily to treat the symptoms of intermittent claudication in people with peripheral artery disease (PAD). By improving blood flow and reducing pain while walking, Cilostazol helps patients increase their physical activity and enhance their quality of life.\n\nKey Ingredient and Its Benefits\nCilostazol (50 mg)\nImproved Blood Flow: Cilostazol works by inhibiting phosphodiesterase III, leading to an increase in cyclic AMP levels and vasodilation, which improves blood flow to the limbs.\nReduced Pain: It helps reduce pain and discomfort in the legs caused by poor blood circulation, allowing patients to walk longer distances without pain.\nPlatelet Aggregation Inhibition: Cilostazol inhibits platelet aggregation, reducing the risk of blood clots and improving overall cardiovascular health.\nEnhanced Physical Activity: By alleviating symptoms of intermittent claudication, Cilostazol enables patients to engage in more physical activities and improve their overall fitness.\nBenefits of CILOSTAZONE 50\nEffective Symptom Relief: CILOSTAZONE 50 provides effective relief from the symptoms of intermittent claudication, reducing pain and discomfort in the legs.\nImproved Circulation: The medication enhances blood flow to the limbs, improving circulation and overall vascular health.\nIncreased Mobility: By reducing pain while walking, CILOSTAZONE 50 helps patients increase their mobility and engage in more physical activities.\nPrevention of Blood Clots: Cilostazol’s platelet aggregation inhibition properties help prevent the formation of blood clots, reducing the risk of cardiovascular events.\nDosage and Administration\nDosage\nIntermittent Claudication: The typical dosage for adults is one tablet (50 mg) taken twice daily, 30 minutes before or 2 hours after breakfast and dinner. The dosage may be adjusted by the healthcare provider based on the patient’s response and specific health needs.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It should be taken on an empty stomach, either 30 minutes before or 2 hours after meals.\nConsistency: For optimal results, take CILOSTAZONE 50 at the same times each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/cilostazone-50-133551", "price": 101.5, "discountamount": 30.45, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "PAD", "risk", "legs", "life", "Order", "EMAIL", "meals", "water", "limbs", "adults", "people", "dinner", "quality", "patients", "response", "Benefits", "symptoms", "Oral Use", "formation", "breakfast", "full glass", "blood flow", "Prevention", "same times", "one tablet", "discomfort", "Cilostazol", "blood clots", "Consistency", "bloodstream", "CILOSTAZONE", "vasodilation", "Introduction", "sterisonline", "sterispharma", "Reduced Pain", "empty stomach", "CALL/WHATSAPP", "typical dosage", "Key Ingredient", "overall fitness", "optimal results", "longer distances", "effective relief", "cyclic AMP levels", "Increased Mobility", "healthcare provider", "physical activities", "Improved Circulation", "Administration Dosage", "cardiovascular events", "specific health needs", "phosphodiesterase III", "poor blood circulation", "overall vascular health", "Effective Symptom Relief", "intermittent claudication", "peripheral artery disease", "Enhanced Physical Activity", "consistent medication levels", "overall cardiovascular health", "platelet aggregation inhibition properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1814, "imageuri": "https://productimages.withfloats.com/actual/6669749f8c6c791fd3b355dc.png", "tileimageuri": "https://productimages.withfloats.com/tile/6669749f8c6c791fd3b355dc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T10:12:44.844Z", "updatedon": "2024-06-27T06:01:50.923Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cilostazone-50-/1814", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CILOSTAZONE 50 ", "category": "NEUROLOGY RANGE", "tags": [ "CILOSTAZONE 50", "Cilostazol 50mg price", "Cilostazol (50mg)", "Cilostazol 50 uses", "cilostazol 50 mg side effects", "cilostazol 50 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f081d8da3a81d5c69e8ec", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN 10 ", "description": "GLIDAPAFLOZIN 10 \nDapagliflozin (10mg)\nIntroduction\nGLIDAPAFLOZIN 10 is a highly effective medication formulated specifically for the treatment of Type 2 diabetes. This oral tablet contains 10 mg of Dapagliflozin, an SGLT2 inhibitor that plays a crucial role in managing blood glucose levels and supporting overall cardiovascular health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin operates by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys. This inhibition prevents the reabsorption of glucose back into the bloodstream, promoting the excretion of glucose through urine. This process not only helps lower blood sugar levels but also aids in calorie reduction and weight management.\nBenefits\nGLIDAPAFLOZIN 10 is particularly beneficial for patients looking to control their blood sugar levels effectively while also addressing other metabolic aspects like weight and blood pressure. It has been associated with cardiovascular benefits, making it a preferred choice for diabetic patients with heart-related concerns.\n\nDosage and Administration\n\nDosage: The recommended starting dose is one 10 mg tablet per day. Dosage adjustments should be based on individual efficacy and tolerability, under the guidance of a healthcare professional.\nAdministration: GLIDAPAFLOZIN 10 should be taken in the morning, with or without food. Consistency in taking the medication at the same time each day is important for maintaining stable glucose levels.\nSide Effects\nThe most common side effects of GLIDAPAFLOZIN 10 include genital and urinary tract infections due to the increased glucose in the urine. Patients may also experience signs of dehydration and low blood pressure. It is important for users to stay well-hydrated and monitor for signs of excessive urination and thirst.\n\nConclusion\nGLIDAPAFLOZIN 10 offers an effective, focused approach to managing Type 2 diabetes through its unique action on renal glucose processing. It simplifies diabetes management by providing a once-daily oral treatment that supports blood sugar control while potentially improving cardiovascular and metabolic health. As with any medication, it is crucial to consult a healthcare provider to tailor the treatment to individual needs and circumstances.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-10-133427\n\n\n\n\n\n", "price": 240.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "Order", "signs", "users", "EMAIL", "urine", "thirst", "choice", "kidneys", "genital", "morning", "guidance", "same time", "Mechanism", "excretion", "Conclusion", "inhibition", "Consistency", "oral tablet", "dehydration", "information", "bloodstream", "Introduction", "reabsorption", "crucial role", "sterispharma", "tolerability", "sterisonline", "GLIDAPAFLOZIN", "circumstances", "CALL/WHATSAPP", "Dapagliflozin", "unique action", "starting dose", "oral treatment", "Type 2 diabetes", "SGLT2 inhibitor", "one 10 mg tablet", "metabolic health", "individual needs", "weight management", "diabetic patients", "calorie reduction", "blood sugar levels", "Dosage adjustments", "low blood pressure", "individual efficacy", "common side effects", "excessive urination", "diabetes management", "healthcare provider", "blood sugar control", "effective medication", "blood glucose levels", "stable glucose levels", "Administration Dosage", "heart-related concerns", "cardiovascular benefits", "healthcare professional", "other metabolic aspects", "urinary tract infections", "renal glucose processing", "effective, focused approach", "sodium-glucose cotransporter", "overall cardiovascular health" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1310, "imageuri": "https://productimages.withfloats.com/actual/665f0820c40ee9be019637c3.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/665f0820c40ee9be019637c3.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:27:09.955Z", "updatedon": "2024-06-04T12:27:09.955Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-10-/1310", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN 10 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ee8be7b387b17ecbcbde3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " SACUBRIGHT 200 ", "description": "SACUBRIGHT 200 \nSacubitril (97mg), Valsartan (103mg)\nSACUBRIGHT 200 is a combination medication containing two active ingredients: Sacubitril (97mg) and Valsartan (103mg). This combination is designed to provide dual inhibition of the renin-angiotensin-aldosterone system (RAAS) for the treatment of heart failure with reduced ejection fraction (HFrEF).\n\nSacubitril is a neprilysin inhibitor, while Valsartan is an angiotensin II receptor blocker (ARB). Together, they work synergistically to improve cardiovascular outcomes in patients with HFrEF by targeting different pathways involved in the pathophysiology of heart failure.\n\nNeprilysin is an enzyme responsible for the degradation of natriuretic peptides, which play a crucial role in regulating blood pressure and fluid balance. By inhibiting neprilysin, Sacubitril increases the levels of natriuretic peptides, leading to vasodilation, natriuresis, and diuresis, which helps reduce blood pressure, preload, and afterload on the heart.\n\nValsartan, as an ARB, blocks the effects of angiotensin II, a vasoconstrictor and stimulator of aldosterone secretion. By antagonizing the angiotensin II type 1 (AT1) receptors, Valsartan dilates blood vessels, reduces blood pressure, and attenuates the deleterious effects of angiotensin II on cardiac remodeling and fibrosis.\n\nSACUBRIGHT 200 is indicated for the treatment of symptomatic HFrEF in patients with New York Heart Association (NYHA) class II-IV heart failure. Clinical studies have demonstrated that this combination therapy reduces the risk of cardiovascular death and hospitalization for heart failure compared to traditional therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) alone.\n\nAs with any medication, SACUBRIGHT 200 may cause side effects, including hypotension, hyperkalemia, renal impairment, and angioedema. Patients should be monitored regularly for these adverse effects, especially during initiation and dose titration.\n\nOverall, SACUBRIGHT 200 represents an innovative approach to the management of HFrEF, offering superior efficacy and cardiovascular benefits compared to standard therapy. However, it should only be used under the supervision of a healthcare professional experienced in the management of heart failure and in accordance with established treatment guidelines.\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/sacubright-200-134307\n\n\n\n", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ARB", "risk", "RAAS", "EMAIL", "Order", "levels", "diuresis", "fibrosis", "patients", "Valsartan", "stimulator", "initiation", "angioedema", "SACUBRIGHT", "accordance", "management", "Sacubitril", "natriuresis", "degradation", "information", "supervision", "hypotension", "sterisonline", "sterispharma", "hyperkalemia", "vasodilation", "side effects", "crucial role", "CALL/WHATSAPP", "fluid balance", "blood vessels", "dose titration", "AT1) receptors", "blood pressure", "dual inhibition", "adverse effects", "pathophysiology", "hospitalization", "vasoconstrictor", "standard therapy", "renal impairment", "Clinical studies", "symptomatic HFrEF", "superior efficacy", "different pathways", "cardiac remodeling", "combination therapy", "deleterious effects", "innovative approach", "traditional therapy", "treatment guidelines", "neprilysin inhibitor", "cardiovascular death", "natriuretic peptides", "angiotensin II type 1", "aldosterone secretion", "two active ingredients", "combination medication", "cardiovascular outcomes", "cardiovascular benefits", "healthcare professional", "reduced ejection fraction", "New York Heart Association", "angiotensin receptor blockers", "angiotensin II receptor blocker", "NYHA) class II-IV heart failure", "renin-angiotensin-aldosterone system", "angiotensin-converting enzyme (ACE) inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1279, "imageuri": "https://productimages.withfloats.com/actual/665ee8c06030c166b1a41ef3.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ee8c06030c166b1a41ef3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T10:13:18.717Z", "updatedon": "2024-06-04T10:13:18.717Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/-sacubright-200-/1279", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril (97mg), Valsartan (103mg)", "category": "CARDIOLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }